Skip to main content
Taiwan OKs Chugai's Hemlibra to treat hemophilia A with inhibitors
12/5/2018

The Taiwan Food and Drug Administration approved Hemlibra from Chugai Pharmaceutical to prevent bleeding episodes in patients with hemophilia A with factor VIII inhibitors. Regulators based their approval on two studies.

Full Story: